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Objective To establish an animal model of sudden onset sensorineural hearing loss (SSNHL) to study its
mechanisms. Materials and methods The inner ear was exposed to 3-nitropropionic acid at 0.5 mol/L (3-NP
(H)) and 0.3 mol/L (3-NP (L)) through the round window membrane for 30 minutes in 50 male guinea pigs.
Thresholds of auditory brainstem responses(ABR) were established before the treatment and retested at 4 hours, 1
day, 3 days and 6 days following 3-NP exposure. Control animals were treated with phosphate buffered saline
(PBS) and their ABRs were retested at 4 hours and 1 day after the treatment. Animals were monitored for
nystagmus and postural signs of vestibular dysfunction, using a digital video camera, following the treatment
procedure. Specimens were taken at 12 hours, 1 day, 3 days and 7 days following 3-NP(H) exposure and embedded
in JB4 for light microscopy observation. Results ABRs were lost in all animals tested at 4 hours following 3-NP
(H) exposure. The rate of complete ABR loss decreased as post-treatment test time increased. ABRs were lost in
80% (4/5) of the animals at 1 day after exposure to 3-NP (L). Spontaneous horizontal nystagmus with a fast phase
away from the treated ear developed in all 3-NP (H)-treated animals and in 20 % ( 1/5) of the animals exposed to
3-NP (L), except for the one treated bilaterally. Various degree of postural disturbances consistent with unilateral
vestibular dysfunction, such as spontaneous barrel rolling towards the exposure side while walking, were seen in
all animals exposed to 3-NP(H) and 40% (2/5) of animals exposed to 3-NP(L), except for the one animal treated
bilaterally, which showed no signs of imbalance. Both nystagmus and postural disturbances resolved in 2 days
following 3-NP exposure. Histological study showed temporary edema tin the organ or Corti, Claudius cells and
the inner sulcus cells 3 days after 3-NP (H) treatment. Enlargement of intercellular space in the spiral prominence
was first noticed at 12 hours post-3-NP (H) exposure, progressed at day 3 and recovered at day 7. Vacuoles in the
cellular plasm and nucleus was seen as early as at 12 hours post-3-NP exposure in the spiral ganglion cells, and
signs of degeneration were visible at day 7. Conclusion Inner ear exposure to 3-NP through the round window
membrane appears to reproduce clinic manifestations and may serve as a legitimate animal model of SSNHL
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Introduction
Sudden onset sensorineural hearing loss (SSNHL)
is an acute hearing impairment, and is thought to affect
1:10, 000 people annually［1］. SSNHL is usually defined
as a greater than 30 dB sensorineural hearing loss
occurring at three contiguous audiometric frequencies
or more over 72 hours or less［2］. Even with extensive
clinical and laboratory work-up, an etiology can be
identified in only 10% to 15% of patients with
SSNHL. Viral infection, vascular compromise and
cochlear membrane ruptures are a few entities
associated with or hypothesized to cause SSNHL［3-6］.
Up to 90% of patients suffering from SSNHL also
complain of tinnitus［7］. The incidence of vertigo is
variable and may depend on different origins of the
SSNHL. Overall, the incidence of vertigo in SSNHL is
36% ［8］. In vertebrobasilar ischemia-induced sudden
sensorineural hearing loss, the incidence of vertigo is
97%(28/29)［9］. It has been reported that vertigo appears
more frequently in association with profound hearing
loss and that hearing recovery is poorer with than
without vertigo［10-12］.
That herpes simplex type 1(HSV-1) is the main
virus causing SSNHL has been demonstrated by
detecting HSV-1 specific DNA in the geniculate,
vestibular and spiral ganglia of individual human
temporal bones, by clinical observations and by MRI
studies［13-15］. It has also been reported that synthesis of
mitochondrial proteins in infected cells decreases
progressively, dropping to about 60% of normal
level［16,17］. ATP produced by mitochondrial in the HSV
infected cells declines significantly 12 hours post
infection［18］. Vascular compromise, the second main
cause of SSNHL, also induces cell damage through
mitochondrial dysfunction. The activities of complex I
and III in the mitochondrial respiratory chain are much
reduced during cardiac ischemia and reperfusion［19, 20］.
Further, mitochondrial deletion has been found in a
patient presenting with bilateral SSNHL ［21］.
Mitochondrial dysfunction is therefore hypothesized to
be a key step in SSNHL pathphysiology. A
mitochondrial toxin, 3-nitropropionic acid (3-NP) is an
irreversible inhibitor of succinate dehydrogenase in the
mitochondrial respiratory chain ［22］. The aim of the
present study is to establish an animal model of
SSNHL using 3-NP administered to the inner ear
through the round window membrane, to be used in
studies for better understanding and treatment of
SSNHL.
Materials and methods
Reagents
3-nitropropionic acid(3-NP) (Sigma-Aldrich
Chemical Co., St. Louis, MO, USA) solutions at 0.5
mol/L and 0.3 mol/L were prepared using saline.
Using JB4 TM Embedding Kit (Electron Microscopy
Sciences), infiltration solution was made by adding
0.625g Plasticized (catalyst) in 50 ml JB-4 solution A
(Benzoyl Peroxide) while stirring on a magnetic stirrer.
The solution was stored at 4℃ . Fresh embedding
solution was prepared before use by adding 1.0 ml
JB-4 solution B (accelerator) to 25 ml infiltration
solution.
Aminals
Fifty male guinea pigs (170 to 250 g), obtained
from Shanghai Institute of Pharmacology, Chinese
Academy of Science, were used in the study. The study
protocol was reviewed and approved by the Animal
Experiment Committee of Shanghai Jiaotong
University School of Medicine. Animals were
randomly selected into 7 Groups (see Table 1), based
upon the type of exposure agent and timing of
post-exposure ABR recording.
All experiments procedures were conducted under
general anaesthesia induced and maintained with
xylazine (16 mg/kg) and ketamine (60 mg/kg).
3-NP delivery
The inner ear was exposed to 3-NP or PBS
through the round window membrane. In addition to
general anaesthesia, lidocaine was given locally before
incision. PBS (0.01 mol/L, pH 7.3) was sterilized in an
autoclave, and 3-NP(H) and 3-NP(L) were sterilized by
passing through a 0.22 μm filter. Local skin around the
left ear was shaved and disinfected and eyes were
protected with erythromycin optic ointment. Under an
operating microscope, the bulla was opened through a
retro-auricular approach and the round window niche
identified. Six micro liter of 3-NP was delivered in the
round window niche followed by placement of a piece
of 3-NP saturated gelfoam that was left in place for 30
minutes. The gelfoam was then removed and the bulla
packed with a muscle flap before wound closure. For
control animals in Groups VI and VII, procedures were
the same except that PBS was used instead of 3-NP.
One animal in Group II received 3-NP(H) exposure in
both ears. All animals received Ciprofloxacin
Hydrochloride intraperitoneally once a day following
the procedure.
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ABR measurement
ABRs were recorded with an ICS CHARTR EP
Auditory Evoked Potential System (GN Otometrics,
Denmark). Stimuli were clicks with a duration of 50 μs
presented at a repetition rate of 21.1/s. Responses from
500 sweeps were averaged with a gain of 100k at each
intensity level after being filtered through a filter of 0.1
kHz - 3 k Hz. Thresholds were visually determined by
identifying reproducible waveforms. ABRs
measurements were taken before the experiment and
repeated following exposure to 3-NP or PBS at various
time intervals (see Table 1). The contralateral cochlea
was destroyed before the final ABR measurement in
groups I, II, III, IV and V.
Vestibular function tests
Animal activities and spontaneous nystagmus fol-
lowing exposure to 3-NP were recorded with a digital
video camera(Canon MV 530i, Japan). The observa-
tions were conducted within 2 hours after exposure. Se-
vere postural disturbances were defined as circular
walking, head tilt and spontaneous barrel rolling while
walking. A slight postural disturbance was defined as
mere head tilt without any other postural disturbances.
Plastic embedding based morphology
AUnder general anaesthesia, animals were
sacrificed at various time intervals following 3-NP
exposure(see Table 1). Cardio perfusion with 4%
paraformaldehyde and 1 % glutaraldehyde in 0.1 mol/L
PBS(pH 7.4) was performed after removing the blood
by perfusion with 0.01 mol/L PBS(pH 7.4). The bulla
was removed and fixed with the same fixative solution
overnight. After washing with 0.1 mol/L PBS,
specimens were emerged in 10% EDTA at room
temperature for at least 4 weeks for decalcification.
They were then dehydrated in steps with 35% , 70% ,
90% and 95% ethanol each for 10 minutes, and then in
absolute ethanol for 15 minutes twice. This was
followed by infiltration in JB-4 infiltration solution of
at least 10 times the specimen volume at room
temperature for 60 min, 3 times by rotation, and then
embedding in the embedding solution at 4℃ for 2 days.
After being dried in a desiccator for at least 2 days,
2 μm sections were prepared on a microtone section
machine (LEICA RM2265, Germany), and stained
with toluidine blue for light microscopy observation.
Statistical analysis
Percentages of complete loss of ABR, ABR
threshold shift greater than 60 dB, between 30 dB and
59 dB, between 15 dB and 29 dB, as well as
percentages of findings of nystagmus and postural
impairment were compared among the groups. Fisher's
Exact Test was used for significance analyses.
Results
Two animals in Group III and one animal in
Group IV died before their post-treatment ABR tests,
probably from dehydration as they were unable to
drink water for severe postural disturbances.
Vestibular Dysfunction
All animals showed neither nystagmus nor
postural disturbances before 3-NP exposure.
Spontaneous horizontal nystagmus with a fast phase to
the right (opposite to the operated ear) developed in all
animals exposed to 0.5 mol/L 3-NP and in 2 of the 5
animals exposed to 0.3 mol/L 3-NP. Severe postural
disturbances indicative of unilateral vestibular loss
Group
I
II
III
IV
V
VI
VII
No. of Animals
5
11*
13**
5
5
5
5
Exposure Agent
3-NP (H)
3-NP (H)
3-NP (H)
3-NP (H)
3-NP (L)
PBS
PBS
Time of ABR Following Exposure
4 hours
1 day
3 days
6 days
1 day
4 hours
1 day
Time of Histology Following Exposure
8-12 hours
-
3 days
7 days
-
8-12 hours
-
Table 1. Animal groups
*Two animals died before post-procedure ABR measurement.
** One animal died before post-procedure ABR measurement.
Cochlear samples from groups II and VII were taken for electron microscopy study (data not shown).
3-NP (H): 0.5 mol/liter; 3-NP (L): 0.3 mol/liter.
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with spontaneous barrel rolling towards the operated
side while walking developed in 67.5% (23/34) of the
animals exposed to 0.5 mol/L 3-NP and 20% (1/5) of
the animals exposed to 0.3 mol/L 3-NP. Slight postural
disturbances with only head tilt developed in 32.4%
(11/34) of the animals exposed to 0.5 mol/L 3-NP and
in 20% (1/5) of the animals exposed to 0.3 mol/L 3-NP
(Table 2). The animal that received bilateral 3-NP
exposure showed no postural disturbances. Both
spontaneous nystagmus and postural disturbances
resolved within 2 days of exposure. No animal treated
with PBS showed nystagmus or postural disturbances.
The differences between different groups were
statistically significant (p < 0.01).
ABR changes
The average pre-exposure baseline ABR threshold
for the guinea pigs used in this study was 7.4 ± 7 dB
nHL. Subsequent to 0.5 mol/L 3-NP exposure, ABRs
were completely lost in animals tested at 4 hours
post-treatment. Animals tested at later times
demonstrated various degrees of ABR threshold shifts
at variable rates (Table 3). The rate of complete ABR
loss decreased as post-treatment test time increased.
ABRs were not detectable in 80% (4/5) of the animals
tested at 1 day after exposure to 0.3 mol/L 3-NP (Table
3). No significant ABR threshold change was noticed
in animals treated with PBS. The differences between
different groups were statistically significant (p <
0.01).
Morphological changes
The fine structures of the cochlea were demonstrat-
ed with the JB-4 embedding method. Endolymphatic
hydrops was not present in either PBS or 3-NP treated
animals(Figure 1). In stead, edema was noticed in the
Corti's organ, Claudius cells and inner sulcus cells at 3
days post-3-NP treatment, and went away at day 7 (Fig-
ure 2). Cells of the spiral prominence started to show
intercellular space enlargement within 12 hours
post-3-NP treatment, which increased at day 3 and dis-
appeared at day 7 (Figure 3). Vacuolar formation was
found in cytoplasm of spiral ganglion cells as early as
within 12 hours following 3-NP exposure, with en-
larged space between the myelin and cell body. The
vacuole disappeared from the cellular plasm and the nu-
cleus at day 7, but the enlarged space between the cell
body and the myelin remained(Figure 4). This was ac-
companied by cell body shrinkage and condensed stain-
ing, indicating a degenerating process within the neu-
ron.
Discussion
The current study showed deterioration of ABRs
and signs of vestibular dysfunction in animals
following inner ear exposure to 3-NP at 0.5 mol/L or
Exposure Agent
3-NP (H)
3-NP (L)
PBS
No. of Animals
34**
5
10
Spontaneous nystagmus
No. (%)
34 (100)
2(40)
0 (0)
Severe postural disturbances*
No. (%)
23 (68)
1(20)
0 (0)
Mild postural disturbance*
No. (%)
11 (32)
1(20)
0 (0)
Table 2. Signs of vestibular dysfunction following the exposure procedure
* See Materials and Methods for definition of "severe" and "mild" postural disturbance.
3-NP (H): 0.5 mol/liter; 3-NP (L): 0.3 mol/liter.
Group
I
II
III
IV
V
VI
VII
ABR lost No. (%)
5 (100)
10 (91)
6 (55)
1 (20)
4(80)
0 (0)
0 (0)
ABR present with threshold
shift > 60 dB No. (%)
0 (0)
0 (0)
5 (45)
3 (60)
0(0)
0 (0)
0 (0)
ABR threshold shift between
30 and 59 dB No. (%)
0 (0)
1 (9)
0 (0)
1 (20)
0(0)
0 (0)
0 (0)
ABR threshold shift between
15 and 29 dB No. (%)
0(0)
0(0)
0(0)
0(0)
1(20)
0 (0)
0 (0)
Table 3. ABR changes following the exposure procedure
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0.3 mol/L for 30 minutes through the round window
membrane. Disturbances in hearing and vestibular
functions were more severe in animals exposed to 0.5
mol/L 3-NP than 0.3 mol/L 3-NP. These were
accompanied by morphological changes in the organ of
Corti, Claudius cells, the inner sulcus cells, the spiral
prominence, and the spiral ganglion cells 7.
Hoya, et al. reported a novel animal model of
acute cochlear mitochondrial dysfunction ［23］. They
observed no vertigo at the concentrations of 3-NP used
in their study (0.05 mol/L, 0.3 mol/L, 0.5 mol/L). A
difference in our study is the greater volume of 3-NP
than reported in their study. The 30 minutes exposure
to 3-NP-immersed gelfoam placed on the round
window membrane, compared to the 2 minutes
infusion reported in Hoya's study, may have increased
3-NP passage into the inner ear. The extended exposure
provided by gelfoam permeation may also have
allowed direct 3-NP diffusion into the vestibule via the
ligament around the oval window. The relatively small
volume of the 3-NP permeated into the scala tympani
in the Hoya study may have been easily diluted
through diffusing to the cerebrospinal fluid via the
cochlear aqueduct［23, 24］. The continuous decline in the
number of animals with complete ABR loss over time
observed in this study may indicate hearing recovery.
The mechanism of 3-NP-induced cell death is
Figure 1. Cross sections of the cochlea after PBS (a)
and 3-NP(b) exposure. Neither PBS nor 3-NP (H)
exposure has caused endolymphatic hydrops. (scale
bar = 1000 μm)
Figure 2. Morphological changes in the scala media after
PBS and 3-NP (H) exposure. a. Normal morphology in PBS
exposed cochlea. b. No pathological change in the scala
media 12 hours post-3-NP (H) administration. c. Edema in
the Corti's organ, Claudius cells and inner sulcus cells 3
days post-3-NP (H) delivery. d. Edema went away in the
Corti's organ, Claudius cells and inner sulcus cells 7 days
post-3-NP (H) exposure. ISC-inner sulcus cells, CO-Corti's
organ, CC-Claudius cells. (scale bar = 100 μm)
Figure 3. Morphological changes in the cochlear lateral
wall after PBS and 3-NP (H) exposure. a. The fine structures
around the spiral prominence are intact after PBS
administration. b. The intercellular space of the spiral
prominence started to be enlarged 12 hours post-3-NP (H)
treatment. c. The enlarged intercellular space of the spiral
prominence has increased 3 days after 3-NP (H) exposure. d.
The enlarged intercellular space of the spiral prominence
recovered at day 7. (scale bar = 100 μm)
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conducted via Caspase-dependent and -independent
pathways as observed in rat cortical neurons［25］. The
pathology of 3-NP-induced hearing loss has been
shown to be degeneration of the lateral wall in the
cochlea［26］. An enlarged extracellular space has been
found with type II fibrocytes around the spiral
prominence 3 hours after 3-NP delivery at a
concentration of 0.5 mol/L ［26］. Our findings of
morphological changes at the spiral prominence is in
agreement with the literature［26］. The spiral ganglion
cell damage in our study, spiral ganglion cells by
toluidine blue indicates degenerating procedure
happened in the neuron［27］ not previously reported in
the literature, may be caused by extensive distribution
of 3-NP ［26］. The condensed staining of the.
Administration of 3-NP into the brain has been
reported to induce oxidative stress［28-30］. The fact that
early pathological changes are present in spiral
ganglion cells, but not in the cochlear hair cells,
indicates spiral ganglion cells' higher sensitive to
energy insufficiency than hair cells. The pathological
changes in the spiral prominence and spiral ganglion
cells may be involved in the development of permanent
hearing loss by disrupting potassium circulation in type
II spiral ligament fibrocytes and affecting conduction
of electrophysiological signals［31, 32］.
The spontaneous nystagmus and postural
disturbances in unilaterally treated animals suggest a
peripheral vestibular paresis on the side of 3-NP
exposure, likely related to mitochondrial dysfunction.
These signs are also consistent with clinical
manifestation of vestibular dysfunction in SSNHL.
There appears to be a dose-effect relationship in
vestibular dysfunction caused by 3-NP. The relatively
short time needed for resolution of vestibular signs
may be explained by the possibility that, compared to
the cochlea, the vestibule is more resistant to ATP
shortage, probably because it is metabolically less
active than the cochlea. The literature has suggested
that recovery from disequilibrium is accomplished by
regeneration of vestibular peripheral inputs and
compensation at the central nervous system level［33］.
This process can not take place within a few days and
can not be used to explain the fast vestibular recovery
in our animal model.
Conclusion
The authors believe that the current work
represents an improved animal model for investigating
mechanisms of SSNHL, as it includes manifestation of
Figure 4. Morphological changes of the spiral ganglion
cells after PBS and 3-NP(H) exposure. a. Normal spiral
ganglion cells with dominantly type I cells (big arrow) and
seldom type II cells (small arrow) were demonstrated in the
PBS treated cochlea. b. Vacuolar formation in the cellular
plasm (small arrow) and nucleus (thick arrow) of spiral
ganglion cells within 12 hours following 3-NP(H)
administration, and enlarged space between the myelin and
cell body (big arrow). c. No vacuoles visible in the cellular
plasm of spiral ganglion cells at day 7. However, note
shrunken cell body and condensed staining, with an
enlarged space between the cell body and the myelin (big
arrow). (scale bar = 10 μm)
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vestibular dysfunction, which is an important aspect of
the condition. The study also supports the notion that
presence of vestibular dysfunction represents a severe
form of SSNHL, in which hearing loss is often
irreversible［34-36］.
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